MD Anderson and P-Cure join hands to advance proton and helium ion therapy
The University of Texas MD Anderson Cancer Center and P-Cure Ltd. today announced a strategic alliance to advance the development and clinical validation of a next-generation particle therapy platform designed to deliver both proton and helium ion therapy from a single compact upright treatment system.
Read original article on The Medical News →Related news
-
Childhood cancer cells shape-shift to spread without genetic mutations
United Kingdom
-
AI assesses what really matters to people in health care—well-being
United Kingdom
-
Early trial results suggest potential new treatment for stiff person syndrome
United Kingdom
-
US youths see nearly 4,000 food marketing messages on digital media each year
United Kingdom
-
A brief history of the food pyramid – and its many false starts
Australia
-
Fish Stocks Thrive Thanks to This Pink Seaweed and Locals Who Protected It
United Kingdom
-
It takes a neighborhood to keep kids active
United Kingdom
-
Two-year study will examine how gender-affirming hormone therapy affects energy use and blood vessel function
United Kingdom